Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Hydrocortisone
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Hydrocortisone 1% lotion
1304000V0AABRBR
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | No data available |
|
Hydrocortisone 1%/Salicylic acid 1%/Sulfur 1% in Aqueous crm
1304000V0AAESES
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | No data available |
|
Hydrocortisone 100mg/5ml oral suspension
0603020J0AACACA
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
|
Hydrocortisone 12.5mg/5ml oral suspension
0603020J0AABBBB
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
|
Hydrocortisone 13.95mg/5ml oral suspension
0603020J0AACLCL
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
|
Hydrocortisone 18mg/5ml oral suspension
0603020J0AACTCT
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
|
Hydrocortisone 1mg capsules
0603020J0AABTBT
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
|
Hydrocortisone 1mg/5ml oral suspension
0603020J0AABDBD
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
|
Hydrocortisone 2.5% / Sulfur 1% in Aqueous cream
1304000V0AAFBFB
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | No data available |
|
Hydrocortisone 2.5% in White soft paraffin
1304000V0AAEJEJ
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | No data available |
|
Hydrocortisone 2.5mg capsules
0603020J0AAA5A5
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
|
Hydrocortisone 2.5mg/5ml oral suspension
0603020J0AABCBC
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
|
Hydrocortisone 2.6mg/5ml oral suspension
0603020J0AABWBW
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
|
Hydrocortisone 2% in White soft paraffin
1304000V0AAFAFA
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | No data available |
|
Hydrocortisone 2% lotion
1304000V0AAENEN
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | No data available |
|
Hydrocortisone 200mg suppositories
0105020C0AAAEAE
|
Hydrocortisone (Rectal) | Hydrocortisone | Gastro-Intestinal System | No data available |
|
Hydrocortisone 20mg modified-release capsules
0603020J0AADMDM
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
|
Hydrocortisone 20mg/5ml oral suspension
0603020J0AABVBV
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
|
Hydrocortisone 250micrograms/5ml oral suspension
0603020J0AABZBZ
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
|
Hydrocortisone 2mg capsules
0603020J0AABRBR
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
|
Hydrocortisone 2mg/5ml oral suspension
0603020J0AABMBM
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
|
Hydrocortisone 3.6mg/5ml oral suspension
0603020J0AACJCJ
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
|
Hydrocortisone 3.75mg/5ml oral suspension
0603020J0AACDCD
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
|
Hydrocortisone 30mg/5ml oral suspension
0603020J0AABYBY
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
|
Hydrocortisone 3mg/5ml oral suspension
0603020J0AABNBN
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.